In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder-Reference-Cited by-同舟云学术

In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder

Published:2018-08-14 Issue:2 Volume:367 Page:267-281
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Bidlack Jean M.^ORCID,Knapp Brian I.,Deaver Daniel R.,Plotnikava Margarita,Arnelle Derrick,Wonsey Angela M.,Fern Toh May,Pin Sokhom S.,Namchuk Mark N.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference42 articles.

1. Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice;Almatroudi;Br J Pharmacol,2018

2. Bioluminescence Resonance Energy Transfer Assays Reveal Ligand-specific Conformational Changes within Preformed Signaling Complexes Containing δ-Opioid Receptors and Heterotrimeric G Proteins

3. CLINICAL ACTIONS OF FENTANYL AND BUPRENORPHINE

4. Buprenorphine Treatment of Refractory Depression

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach;PLOS ONE;2024-07-11

2. Precipitated opioid withdrawal in a patient started on olanzapine/samidorphan;The American Journal of Emergency Medicine;2024-05

3. Pharmacokinetic Properties of an FDA‐approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose;Clinical Pharmacology in Drug Development;2023-07-27

4. Machine-learning repurposing of DrugBank compounds for opioid use disorder;Computers in Biology and Medicine;2023-06

5. Validation of a pharmacological imaging challenge using 11C-buprenorphine and 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography to study the effects of buprenorphine to the rat brain;Frontiers in Neuroscience;2023-05-10